1. What Is the Heart Valve Market?
The Heart Valve Market covers the prosthetic and repair devices used to replace or repair diseased heart valves, supplied to cardiac surgery programmes and structural heart intervention centres. Cardiac surgeons and interventional cardiologists use heart valve devices to restore normal valve function in patients with aortic stenosis, mitral regurgitation, and other valvular diseases. The market serves surgical valve replacement, transcatheter valve replacement and repair, and minimally invasive valve surgery across cardiothoracic surgery and interventional cardiology. It includes tissue and mechanical surgical valves, transcatheter aortic valve replacement systems, transcatheter mitral devices, and annuloplasty rings, with demand driven by ageing populations with rising valvular disease burden and the expansion of transcatheter approaches to broader patient populations.
2. Heart Valve Market Size & Forecast
3. Emerging Technologies
- Transcatheter aortic valve replacement systems enabling catheter-based aortic valve replacement for all surgical risk categories.
- Transcatheter mitral leaflet repair devices treating mitral regurgitation without open surgery.
- Surgical tissue valves with anti-calcification treatment extending prosthetic valve durability.
- Next-generation tricuspid transcatheter repair and replacement devices for a previously untreatable population.
Similar technologies are also transforming adjacent markets. Learn more in our Surgical Navigation Market.
4. Key Market Opportunity
The largest near-term opportunity in the Heart Valve market lies in cardiac surgery programmes adopting TAVR for all aortic stenosis risk categories as evidence extends across the risk spectrum. A second, faster-growing opportunity lies in structural heart centres building MitraClip programmes for functional and degenerative mitral regurgitation. As adoption broadens, the addressable opportunity is expanding from early deployments toward wider commercial use, with Europe positioned for the most rapid growth through 2034.
5. Top Companies in the Heart Valve Market
The following organisations hold leading positions in the Heart Valve Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Edwards Lifesciences
- Medtronic
- Abbott Structural Heart
- Boston Scientific
- JenaValve
- Anteris Technologies
- Neovasc
- Tendyne (Abbott)
- LivaNova
- Cryolife
6. Market Segmentation
The Heart Valve Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Procedure | Surgical Valve Replacement Transcatheter Aortic Valve Replacement Transcatheter Mitral and Tricuspid |
| By Valve Type | Tissue Mechanical Transcatheter |
| By Application | Aortic Mitral Tricuspid |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Heart Valve Market trajectory over the forecast period:
Transcatheter Aortic Valve Replacement Has Transformed Aortic Stenosis Treatment.Transcatheter aortic valve replacement has transformed aortic stenosis treatment, as the catheter-based approach enables valve replacement without open-chest surgery in patients who previously faced prohibitive surgical risk. Edwards Lifesciences' Sapien and Medtronic's CoreValve systems have accumulated extensive clinical evidence across all risk categories from extreme to low surgical risk. The expansion of TAVR to low-surgical-risk patients has greatly broadened the eligible patient population. This indication expansion has driven rapid TAVR procedure volume growth. The catheter approach has made aortic valve replacement accessible to elderly and frail patients who are the predominant disease demographic.
Transcatheter Mitral Valve Repair Using Abbott's MitraClip Has Created a Structural Heart Intervention.Transcatheter mitral valve repair using Abbott's MitraClip has created a structural heart intervention for mitral regurgitation patients not suitable for surgery. This leaflet-clip approach reduces regurgitation without valve replacement and has expanded the treatment population for mitral valve disease. The pivotal COAPT trial established survival benefit in functional mitral regurgitation patients, supporting reimbursement expansion. Transcatheter tricuspid repair is an emerging frontier with several devices in clinical trials. The expansion beyond aortic into mitral and tricuspid transcatheter devices is the next structural heart growth wave.
Tissue Valve Durability Has Advanced.Tissue valve durability has advanced, as newer surgical tissue valves using anti-calcification treatments extend prosthetic valve life and reduce reoperation rates. This improvement sustains surgical valve demand alongside growing transcatheter volumes.
For related market intelligence, see the Laparoscopic System Market.
8. Segmental Analysis
By procedure, the transcatheter aortic valve replacement segment dominated the Heart Valve Market in 2025, as TAVR represents the fastest-growing and highest-revenue heart valve procedure category.
By application, the mitral segment is projected to register the highest CAGR in the Heart Valve Market through 2034, as transcatheter mitral repair and replacement devices expand the treatable mitral regurgitation population, driving the fastest-growing application category within the market.
9. Regional Analysis
Regional demand patterns across the Heart Valve Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Heart Valve Market in 2025, accounting for the largest share of revenue. Moreover, the United States leads through the highest TAVR procedure volume globally, a mature structural heart programme infrastructure, and premium pricing for transcatheter devices. In addition, edwards Lifesciences and Medtronic concentrate domestic TAVR sales. The breadth of reimbursement coverage across risk categories and the high procedure rates sustain revenue leadership.
Highest CAGR Region
Europe is projected to register the highest CAGR in the Heart Valve Market through 2034. The primary driver is the broad expansion of TAVR across European markets including Germany, France, and the United Kingdom where transcatheter programmes are scaling. Moreover, transcatheter mitral and tricuspid device adoption is growing fastest in European centres pursuing structural heart programmes. The combination of these demand drivers and an expanding base positions Europe for sustained growth outperformance through 2034.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Heart Valve Market was valued at USD 8.47 Bn in 2025 and is projected to reach USD 19.02 Bn by 2034, growing at a CAGR of 9.4% over the 2026–2034 forecast period.
The Heart Valve Market is projected to grow at a CAGR of 9.4% from 2026 to 2034.
North America dominated the Heart Valve Market in 2025, accounting for the largest share of revenue.
The leading companies in the Heart Valve Market include Edwards Lifesciences, Medtronic, Abbott Structural Heart, Boston Scientific, JenaValve, Anteris Technologies, Neovasc, Tendyne (Abbott), LivaNova, Cryolife.
Transcatheter aortic valve replacement has transformed aortic stenosis treatment.
By procedure, the transcatheter aortic valve replacement segment dominated the Heart Valve Market in 2025, as TAVR represents the fastest-growing and highest-revenue heart valve procedure category.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.